Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Takeda to Manufacture and Provide 150 Million Doses of Novavax’ COVID-19 Vaccine Candidate to the Government of Japan
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
Camila and the Shadow of Dengue:Through a child's eyes
Dengue in Colombia: A young girl's challenge
Dengue in Sri Lanka: One family's struggle
Understanding the Impact of Dengue
